Associated Press Interviews Dr. Terry Heiman-Patterson about Relyvrio, the Third Medication Approved in the United States for ALS

The Associated Press interviewed Terry Heiman-Patterson, MD, Professor of Neurology at the Lewis Katz School of Medicine at Temple University and Director of the Temple MDA/ALS Center of Hope, for an article about Relyvrio. Relyvrio is only the third medication approved in the United States for ALS, or amyotrophic lateral sclerosis. Fortune picked up the Associated Press article.